Komunikaty PR
Biomarker Testing Market to Exceed USD 122.8 Billion by 2033 | DataM Intelligence
2025-06-04 | 14:55:07
Biomarker Testing Market | DataM Intelligence
Biomarker Testing Market- Innovations in genomics, rising chronic disease incidence, and collaborative ventures propel global growth
In Japan, investing in Alzheimer’s and regenerative biomarker research underscores our dedication to seniors and innovation, delivering earlier care.”
AUSTIN, TX, UNITED STATES, June 4, 2025 /EINPresswire.com/ -- It is anticipated that the global biomarker testing market will experience rapid growth, with a valuation of approximately USD 122.8 billion by 2033, and a compound annual growth rate (CAGR) of 10.4% between 2025 and 2033. Biomarker tests, which are molecular indicators of health or illness, are becoming essential instruments for early detection, medication discovery, and therapy monitoring as healthcare transitions to more personalized methods.— DataM Intelligence
Download the sample Copy to explore key trends, innovations shaping the digital pills for mental health market: https://www.datamintelligence.com/download-sample/biomarker-testing-market
Market Overview and Growth Drivers
The biomarker testing industry has experienced significant growth as a result of advancements in bioinformatics, proteomics, and genomics. Key growth drivers include:
• Precision Medicine Adoption: In order to guarantee that patients receive the most effective treatments possible, clinicians and researchers are increasingly utilizing biomarker testing to personalize medications, particularly in the context of cancer.
• Rising Chronic and Infectious Diseases: The significance of early and precise detection is underscored by the increasing prevalence of infectious epidemics, Alzheimer's disease, cardiovascular issues, and cancer.
• Technological Innovations: High-throughput screening, multiplex assays, and next-generation sequencing systems have substantially reduced turnaround times and increased sensitivity, thereby making biomarker profiling more accessible.
• Regulatory Support: Clearer biomarker qualifying requirements have been published by the U.S. Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), which has facilitated the swifter adoption of these markers in the clinical setting.
• R&D Investments: In order to expedite the development of medications and prevent late-stage clinical trial failures, pharmaceutical and biotechnology companies are investing significantly in biomarker identification.
Regional Outlook
North America
The biomarker testing market is primarily dominated by North America, which accounts for approximately 40% of global sales. This leadership is predicated on a robust research infrastructure, significant healthcare expenditures, and the widespread utilization of companion diagnostics in the treatment of cancer. The region's pioneering significance is underscored by the ongoing conduct of large-scale biomarker-driven clinical studies by major university medical facilities and cancer institutes.
Europe
Europe has the second-largest proportion as a result of effective public-private partnerships. The Horizon Europe initiative of the European Union offers substantial funding for biomarker research in a variety of diseases, such as multiple sclerosis and breast cancer. Additionally, the rapid approval of biomarker assays is facilitated by the substantial regulatory support that firms receive in countries such as the United Kingdom, Germany, and France.
Asia-Pacific
The Asia-Pacific region is the fastest-growing category as a result of the expanded disposable income and enhanced healthcare facilities. Japan, China, and South Korea are initiating national genomics initiatives to integrate biomarker testing into standard healthcare. China, in particular, is making substantial investments in digital pathology systems and precision oncology laboratories, which are propelling market growth. Biomarker endpoints are also being adopted by India's expanding clinical trial sector in order to adhere to global standards.
Industry Momentum: Mergers, Partnerships, and Growth 2024–2025
As the biomarker testing space becomes more competitive, companies are forging alliances and executing mergers to enhance their technological capabilities and broaden geographic reach:
• Roche & Foundation Medicine (March 2024): Roche completed its acquisition of Foundation Medicine, strengthening its portfolio of genomic profiling assays and companion diagnostics.
• Thermo Fisher Scientific & QIAGEN (July 2024): Thermo Fisher formed a strategic partnership with QIAGEN to co-develop next-generation sequencing panels for rare disease biomarkers, leveraging Thermo Fisher’s instrumentation and QIAGEN’s assay expertise.
• Illumina & GRAIL (January 2025): Illumina finalized its merger with early cancer detection company GRAIL, integrating liquid biopsy technology to accelerate non-invasive cancer screening programs.
• Bio-Rad Laboratories & Pacific Biosciences (September 2024): Bio-Rad acquired Pacific Biosciences’ high-accuracy sequencing module, aiming to enhance its digital PCR-based biomarker assays.
• Agilent Technologies & OncoDNA (February 2025): Agilent entered into a co-development agreement with European precision oncology firm OncoDNA to expand biomarker panels for personalized cancer treatment.
Competitive Landscape:
The major global players in the market include Merck KGaA, Abbott Laboratories, Thermo Fisher Scientific Inc., Q2 Solutions, IQVIA, Inc., QIAGEN N.V., Bio-Rad Laboratories, Inc., Illumina, Inc., Labcorp Drug Development, Quanterix Corporation, and among others.
Latest Developments
Beyond strategic consolidations, recent technological breakthroughs and real-world applications continue to reshape the market:
• Liquid Biopsy Advancements: Companies are developing blood-based diagnostics that are highly sensitive and can detect circulating tumor DNA (ctDNA). This technology enables the early diagnosis of recurrence and the minimum residual disease surveillance in cancer patients.
• Multiplex Proteomic Assays: The simultaneous measurement of hundreds of protein biomarkers is made possible by new mass-spectrometry-based technologies, which offer a more comprehensive understanding of neurodegenerative and cardiovascular diseases.
• Point-of-Care Biomarker Devices: The time to treatment is being reduced by testing handheld immunoassay readers for cardiac troponin and inflammatory markers in rural clinics and ambulances.
• Real-World Evidence Integration: Biotech businesses are collaborating with electronic health record (EHR) providers to improve biomarker validation for regulatory approval by correlating biomarker data to clinical outcomes.
Latest News from USA on Biomarker Testing Market:
The United States Centers for Medicare and Medicaid Services (CMS) announced in January 2025 that the payment for next-generation sequencing (NGS)-based biomarker testing across all cancer types will be increased. This will increase patient access to precision diagnostics. Simultaneously, the National Cancer Institute provided USD 75 million in funding to a team led by Johns Hopkins University to verify a panel of early-detection biomarkers for pancreatic cancer. The objective of this initiative is to decrease the disease's notoriously late diagnosis rate.
Latest News from Japan on Biomarker Testing Market:
AMED (Japan Agency for Medical Research and Development) established the "Biomarker Innovation Program" in March 2025. The program aims to identify novel biomarkers for Alzheimer's disease and autoimmune ailments by investing USD 120 million over a five-year period. Additionally, Japan's commitment to translational research is illustrated by the establishment of a new clinical laboratory at Kyoto University's Center for iPS Cell Research, which is committed to the validation of pluripotent stem cell-derived tissue biomarkers for regenerative medicine applications.
Conclusion:
The biomarker testing industry is anticipated to experience accelerated growth as precision medicine becomes more incorporated into clinical processes. The integration of strategic collaborations, technological advancements, and supportive regulatory environments has rendered biomarker tests essential for the optimization of medications, diagnosis, and disease prevention. In order to fully actualize the potential of biomarker-driven healthcare, stakeholders, including diagnostic companies and healthcare providers, must continue to foster innovation and collaboration as the industry matures.
Gain expert insights on market trends, challenges, and future outlook. Buy the Full Report Now and strengthen your strategy with DataM Intelligence:
https://www.datamintelligence.com/buy-now-page?report=biomarker-testing-market
Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription
Related Reports:
Cancer Biomarker Market growth expected to reach up to USD 32.5 bn by 2031
Biomarkers market to grow at a CAGR of 11.9% during 2025-2032
Sai Kumar
DataM Intelligence 4market Research LLP
+1 877-441-4866
sai.k@datamintelligence.com
Visit us on social media:
LinkedIn
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze Prasowym”, których autorami są zarejestrowani użytkownicy tacy jak agencje PR, firmy czy instytucje państwowe.
Ostatnio dodane
komunikaty PR z wybranej przez Ciebie kategorii
EIN Newswire
BRAK ZDJĘCIA
2025-08-15 | 19:55:08
Hundreds of Rural Letter Carriers to Rally in Orlando to Protect the Postal Service from Privatization
Florida Reps. Soto and Frost to Join National Union Presidents in Fight to Protect Postal Workers and the USPSORLANDO, FL, UNITED STATES, August 15, 2025 /EINPresswire.com/ -- On Monday, more than 500 rural letter carriers, other postal workers and their allies, will gather in Orlando to rally against misguided efforts to privatize the United States Postal Service. The rally, which takes place during the National Rural Letter Carriers’ Association (NRLCA) National Convention, will feature Florida Representatives Darren Soto and Maxwell Frost, along with national postal union leaders, demanding Congress safeguard the public Postal Service and the union jobs that keep it running.The rally comes just weeks after a bipartisan majority of the U.S. House signed on to House Resolution 70, affirming that the Postal Service must remain a public institution. The NRLCA is now urging the rest of the Florida delegation to join Reps. Frost and Soto in cosponsoring H. Res. 70. The unions are also urging members of Congress to support the Protect Our Letter Carriers (POLC) Act, which would protect mail carriers from the growing wave of violence and theft.WHAT: NRLCA Rally to Protect the Postal ServiceWHEN: Monday, August 18 · 6:30 PM WHERE: City Commons Plaza, Orlando, FLSPEAKERS INCLUDE:Don Maston, NRLCA National President; Rep. Maxwell Frost (FL-10); Rep. Darren Soto (FL-9); Mark Dimondstein, APWU National President; Bill Braddick, Florida Rural Letter Carriers’ Association President; Nick Mosezar, NPMHU Local 318 President; Al Friedman, NALC Florida President; Byron Shelton, NALC Branch 1091 PresidentThe rally is expected to be the largest public demonstration by rural letter carriers this year, as the NRLCA mobilizes against proposals that would privatize delivery routes and disproportionately hurt rural areas. A memo from Wells Fargo outlines a plan to sell off the most profitable parts of the Postal Service, raise prices by up to 140%, and eliminate union jobs and benefits. Meanwhile, the current administration has signaled it may move the Postal Service under the Department of Commerce—a widely recognized first step toward privatization. These aren’t distant proposals—they’re active threats. And rural letter carriers are sounding the alarm. Rural residents in Florida are particularly vulnerable to the impact of privatization. Nearly two million Floridians—about 9% of the state’s population—live in rural areas, where the Postal Service is often a lifeline. During natural disasters, rural letter carriers have played a critical role in reaching isolated areas and providing emergency access. In many of Florida’s rural and inland communities, USPS is the only delivery option available, as private carriers often refuse to serve areas they deem unprofitable.With rising threats to the public agency’s independence, the rally sends a strong bipartisan message: Florida must stand with the Postal Service and the workers who keep it running.For more information or to arrange interviews with NRLCA President Don Maston, Florida rural carriers, and other speakers, please contact: Melissa Ray, communications@nrlca.org; 571-480-2641.
EIN Newswire
BRAK ZDJĘCIA
2025-08-15 | 19:55:08
EcoBuilders Inc. Addresses Growing Need for Licensed and Insured Contractors in the Gulf South
Hiring licensed and insured contractors is the single most effective way to reduce risk during a construction project. ”— Elwin OrdoyneSLIDELL, LA, UNITED STATES, August 15, 2025 /EINPresswire.com/ -- Across the Gulf South, the demand
EIN Newswire
BRAK ZDJĘCIA
2025-08-15 | 19:55:08
Quick Settlement Offers: Understanding the Risks Before Accepting
A settlement offer made shortly after an injury may not reflect the true value of the claim. ”— William P. MorrowOPELOUSAS, LA, UNITED STATES, August 15, 2025 /EINPresswire.com/ -- In the aftermath of an injury, settlement offers from
Więcej ważnych informacji
Jedynka Newserii
Jedynka Newserii
Konsument
Polacy nie korzystają z hossy trwającej na warszawskiej giełdzie. Na wzrostach zarabiają głównie inwestorzy zagraniczni
Od października 2022 roku na rynkach akcji trwa hossa, nie omija ona także warszawskiej giełdy. Mimo to inwestorzy indywidualni odpowiadają zaledwie za kilkanaście procent inwestycji, a o wzrostach decyduje i na nich zarabia głównie kapitał z zagranicy. Widać to również po napływach i odpływach do i z funduszy inwestycyjnych. Zdaniem Tomasza Koraba, prezesa EQUES Investment TFI, do przekonania Polaków do inwestowania na rodzimej giełdzie potrzeba zysków z akcji, informacji o tych zyskach docierającej do konsumentów oraz czasu.
Wśród Polaków rośnie zainteresowanie produktami emerytalnymi. Coraz chętniej wpłacają oszczędności na konta IKE i IKZE
Blockchain zmienia rynek pracy i edukacji. Poszukiwane są osoby posiadające wiedzę z różnych dziedzin
Polacy odczuwają brak wiedzy na temat inwestowania. Może to sprzyjać podejmowaniu nieracjonalnych decyzji finansowych
Wiedza Polaków o gospodarce i finansach niewystarczająca. To może się przekładać na błędne decyzje inwestycyjne
Investors TFI: Hossa na giełdach nie skończy się przed 2026 rokiem. Wszystko będzie zależeć od trendu na Wall Street
Polityka
Obowiązek zapełniania magazynów gazu w UE przed sezonem zimowym ma zapewnić bezpieczeństwo dostaw. Wpłynie też na stabilizację cen
Unia Europejska przedłuży przepisy z 2022 roku dotyczące magazynowania gazu. Będą one obowiązywać do końca 2027 roku. Zobowiązują one państwa członkowskie do osiągnięcia określonego poziomu zapełnienia magazynów gazu przed sezonem zimowym. Magazyny gazu pokrywają 30 proc. zapotrzebowania Unii Europejskiej na niego w miesiącach zimowych. Nowe unijne przepisy mają zapewnić stabilne i przystępne cenowo dostawy.
Infrastruktura
Gminy zwlekają z uchwaleniem planów ogólnych zagospodarowania przestrzennego. Może to spowodować przesunięcie terminu ich wejścia w życie
Reforma systemu planowania i zagospodarowania przestrzennego rozpoczęła się we wrześniu 2023 roku wraz z wejściem w życie większości przepisów nowelizacji ustawy z 27 marca 2003 roku. Uwzględniono w niej plany ogólne gminy (POG) – nowe dokumenty planistyczne, za których przygotowanie mają odpowiadać samorządy. Rada Ministrów w kwietniu br. uchwaliła jednak ustawę o zmianie ustawy z 7 lipca 2023 roku, a jej celem jest zmiana terminu obowiązywania studiów uwarunkowań i kierunków zagospodarowania przestrzennego gmin na 30 czerwca 2026 roku. Wskazana data może nie być ostateczna z uwagi na to, że żadna z gmin nie uchwaliła jeszcze POG.
Partner serwisu
.gif)
Szkolenia
Akademia Newserii
Akademia Newserii to projekt, w ramach którego najlepsi polscy dziennikarze biznesowi, giełdowi oraz lifestylowi, a także szkoleniowcy z wieloletnim doświadczeniem dzielą się swoją wiedzą nt. pracy z mediami.
|
|
|